Five Prime Therapeutics Competitors and Similar CompaniesClear all
Five Prime Therapeutics's competitors and similar companies include Pharming Group, Aeglea, Odyssey Therapeutics and Olema Oncology.
 Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. |  Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. | |
Founding Date | Founding Date 2001 | Founding Date 1988 | Founding Date 2013 | Founding Date 2021 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Leiden, NL HQ Leiden, NL | Locations Austin, US HQ | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US | Locations San Francisco, US HQ San Francisco, US |
Employees | Employees 5141% decrease | Employees 404 | Employees 65117% increase | Employees 1481% decrease | Employees 9630% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 590.3 m | Valuation ($) 48.6 m | Valuation ($) N/A | Valuation ($) 679.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $13.2m (FY, 2020) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($84.3m) (FY, 2020) | Net income $2.5m (FY, 2025) | Net income ($155.2m) (FY, 2025) | Net income N/A | Net income ($162.5m) (FY, 2025) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 2 (Q3, 2020) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 1 (Q3, 2020) |
Funding | |||||
Total funding raised | Total funding raised $ 237.2m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 386m | Total funding raised $ 145.1m |
For sources of this data, please see the company profile
View Company Profiles
Pharming Group
HQ
Leiden, NL
Employees
404
Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View companyOlema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View company